Emerald Health Therapeutics Inc
F:TBD
Emerald Health Therapeutics Inc
F:TBD
Price:
0.016
EUR
Market Cap:
€6.6m
Balance Sheet
Balance Sheet Decomposition
Emerald Health Therapeutics Inc
Emerald Health Therapeutics Inc
Balance Sheet Decomposition is not available for
Emerald Health Therapeutics Inc
Emerald Health Therapeutics Inc
Balance Sheet
Emerald Health Therapeutics Inc
Emerald Health Therapeutics Inc
Currency: CAD
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
0
|
3
|
45
|
36
|
3
|
26
|
19
|
|
| Cash Equivalents |
0
|
3
|
45
|
36
|
3
|
26
|
19
|
|
| Total Receivables |
0
|
0
|
1
|
19
|
2
|
22
|
2
|
|
| Accounts Receivables |
0
|
0
|
0
|
1
|
0
|
2
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
18
|
2
|
20
|
0
|
|
| Inventory |
0
|
0
|
1
|
8
|
11
|
6
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
0
|
1
|
1
|
|
| Total Current Assets |
0
|
4
|
46
|
64
|
16
|
55
|
22
|
|
| PP&E Net |
0
|
1
|
4
|
27
|
55
|
40
|
18
|
|
| PP&E Gross |
0
|
0
|
4
|
27
|
55
|
40
|
18
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
4
|
15
|
31
|
|
| Intangible Assets |
0
|
0
|
3
|
87
|
20
|
2
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
21
|
26
|
65
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
3
|
1
|
1
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
4
+441%
|
74
+1 665%
|
207
+181%
|
157
-24%
|
98
-37%
|
41
-58%
|
|
| Liabilities | ||||||||
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
3
|
0
|
1
|
4
|
|
| Other Current Liabilities |
1
|
0
|
4
|
24
|
15
|
11
|
0
|
|
| Total Current Liabilities |
1
|
0
|
6
|
36
|
26
|
23
|
7
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
28
|
4
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
2
|
0
|
1
|
1
|
0
|
|
| Total Liabilities |
1
N/A
|
0
-60%
|
8
+1 567%
|
36
+362%
|
53
+44%
|
25
-53%
|
7
-71%
|
|
| Equity | ||||||||
| Common Stock |
3
|
10
|
78
|
205
|
237
|
250
|
253
|
|
| Retained Earnings |
6
|
9
|
17
|
48
|
162
|
205
|
247
|
|
| Additional Paid In Capital |
3
|
3
|
5
|
14
|
28
|
29
|
28
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
4
N/A
|
66
+1 678%
|
170
+159%
|
104
-39%
|
73
-29%
|
34
-54%
|
|
| Total Liabilities & Equity |
1
N/A
|
4
+441%
|
74
+1 665%
|
207
+181%
|
157
-24%
|
98
-37%
|
41
-58%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
46
|
68
|
107
|
141
|
161
|
206
|
213
|
|
Switch to:
Switch to:
See Also
Discover More
